The Chilkoti group carries out research in two areas: (1) Biomolecular Materials, with a focus on genetically encoded stimulus responsive peptide polymers and fusion proteins for application in protein purification and drug delivery; and (2) Biointerface Science, with a focus on protein-polymer conjugates, the development of low-cost, point-of-care clinical diagnostics, and plasmonic biosensors.
“Genetically Encoding Albumin Binding into Chemotherapeutic-loaded Polypeptide Nanoparticles Enhances Their Antitumor Efficacy”, Nano Letters, vol. 18, no. 12, pp. 7784 - 7793, 2018.,
“Genetically Encoded Cholesterol-Modified Polypeptides”, Journal of the American Chemical Society, vol. 141, no. 2, pp. 945 - 951, 2019.,
“Conjugate of Doxorubicin to Albumin‐Binding Peptide Outperforms Aldoxorubicin”, Small, vol. 15, no. 12, p. 1804452, 2019.,